Request made to the UK government to alter medical cannabis policies

Request made to the UK government to alter medical cannabis policies

CMC, the Centre for Medicinal Cannabis, requested the UK government today to alter the medical policies regarding the access of cannabis.

The request was made after the Centre published the results of the largest ever survey in the UK which showed the record-high figures on the number of people accessing cannabis from streets for treatment of diseases diagnosed. The survey was carried upon people from England, Scotland, and Wales. According to the survey, around 2.8 percent of the adult population, equal to 1.4 million people use cannabis for the treatment of chronic diseases.

The report showed that people of all ages, various social classes, and all genders use cannabis for treatment purposes with over £100 per month being spent for such purpose by almost half of the population. Around 9 percent of the studied population, however, revealed that they do not spend any sum of money on the product, instead prefer to grow it themselves or take it from a friend or relative.

It was estimated by CMC, after concluding the results, that cannabis is being used for the treatment of depression by 653,456, for anxiety by 586,188, for arthritis by 230,631, for chronic pain by 326,728, for PTSD by 177,778, and insomnia by 182,583 people across the UK.

It was found by the survey that 56 percent of the self-medicating population belongs to the C2DE social class while 44 percent to the ABC1. The age group, however, varies from 18 years old to 44 years old, around 71 percent of the studied population while it was revealed that people aging over 55 years make 14.6 percent of it.

As is the use frequency concerned, it was revealed by the report that 55.8 percent use cannabis daily, 23.4 percent weekly, and 8.5 percent use it every month.

Parkinson’s disease treatment was highest on the most-spent on per month, costing around £357.

Patients with Huntington’s disease were shown as the most frequent users, figuring to 41.6 percent, schizophrenia to 41.18 percent, Parkinson’s disease to 30.43 percent, Multiple Sclerosis to 19.23 percent, and Post Traumatic Stress Disorder making to 17.37 percent.